vTv Therapeutics KOL breakfast Nov 2017

New York, November 16, 2017

Please join vTv Therapeutics for a KOL breakfast highlighting the Alzheimer's drug discovery landscape and novel mechanisms of action.

Presentations start at 8:30 am EST (registration/breakfast at 8:00 am EDT)


For more information please contact Mike Biega (mbiega@troutgroup.com)

Register / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

vTv Therapeutics, Inc. [VTVT] US$42 MM MCap
Late-stage, Ph. 3 Alzheimer's da­ta read-out ear­ly 2018. Azeli­ra­gon - oral, small-molecule in­hibi­tor of the Re­cep­tor for Ad­vanced Gly­ca­tion End­prod­ucts (RAGE), lies up­stream to AD patholo­gies like... [more in­for­ma­tion]

Event Contact

Mike Biega
Solebury Trout